How is demodex (eye mites) treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Demodex (Eye Mites)

Topical lotilaner ophthalmic solution 0.25% is the FDA-approved first-line treatment for Demodex blepharitis, showing significant reduction in collarettes, mite counts, and eyelid erythema after 6 weeks of twice daily use. 1

Diagnosis and Clinical Presentation

Demodex infestation is responsible for more than two-thirds of all blepharitis cases in the United States 2. Key diagnostic features include:

  • Cylindrical dandruff or "collarettes" at the base of eyelashes (pathognomonic sign) 2, 3
  • Eyelid redness, crusting, and itching
  • Symptoms may include foreign body sensation, burning, and dry eye

The severity of ocular surface discomfort correlates strongly with the number of Demodex mites per eyelash 1.

Treatment Algorithm

First-Line Therapy:

  • Topical lotilaner ophthalmic solution 0.25% - Apply twice daily for 6 weeks 1, 4
    • FDA-approved specifically for Demodex blepharitis
    • Significantly reduces collarettes, decreases mite counts, and reduces eyelid erythema
    • Shows continued benefits through 1 year of follow-up 2

Alternative First-Line Options:

  • Tea tree oil applications 1, 4, 3
    • Weekly 50% tea tree oil eyelid scrubs
    • Daily tea tree oil shampoo scrubs
    • Minimum treatment duration of 6 weeks
    • Contains 4-terpineol as the most effective component 1
    • Caution: Monitor for corneal epithelial defects with higher concentrations 1

Second-Line Therapy (for recalcitrant cases):

  • Ivermectin 1, 4
    • Topical: Weekly ivermectin cream application 1, 4
    • Oral: For severe or resistant cases 1, 4
      • Take with food to increase bioavailability 4
      • Not established for children weighing <15 kg 4

Adjunctive Measures:

  • Eyelid hygiene - Daily cleansing of eyelid margins 1
  • Artificial tears - For associated tear film instability 1
  • Treatment of coexisting conditions - Manage associated dry eye, rosacea, etc. 1

Special Considerations

Treatment Duration

  • Minimum 6 weeks for all therapies 1, 4
  • Continue until clinical improvement and significant reduction in mite counts 4

Safety Precautions

  • Tea tree oil: Use caution with concentrations above 50% due to risk of corneal epithelial defects 1
  • Ivermectin:
    • Consider alternative treatments during pregnancy 4
    • Use with caution in patients with severe liver disease 4
    • Monitor for drug interactions, particularly with azithromycin 4

Treatment Failures

Common reasons for treatment failure include:

  • Inadequate treatment duration 4
  • Failure to treat contacts 4
  • Overlooking immunosuppression 4
  • Neglecting concurrent conditions 4

In-Office Procedures

For cases with significant meibomian gland involvement, consider:

  • Intense pulsed light (IPL) therapy - Shows high Demodex eradication rates compared to topical tea tree oil 1
  • Microblepharoexfoliation combined with tea tree oil scrubs 1

Monitoring Response

  • Follow-up examination after 6 weeks of treatment
  • Assess for:
    • Reduction in collarettes
    • Decreased mite counts on epilated lashes
    • Improvement in symptoms
    • Resolution of eyelid erythema

Successful management of Demodex blepharitis may reduce chronic use of healthcare resources dedicated to managing other ocular surface conditions 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pathogenic role of Demodex mites in blepharitis.

Current opinion in allergy and clinical immunology, 2010

Guideline

Demodicosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.